These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33870183)

  • 21. Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    Gacci M; Andersson KE; Chapple C; Maggi M; Mirone V; Oelke M; Porst H; Roehrborn C; Stief C; Giuliano F
    Eur Urol; 2016 Jul; 70(1):124-133. PubMed ID: 26806655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary proteomics and metabolomics in the diagnosis of pediatric disorders.
    Vaidyanathan K
    Proteomics Clin Appl; 2015 Jun; 9(5-6):482-9. PubMed ID: 25631340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
    Jin R; Strand DW; Forbes CM; Case T; Cates JMM; Liu Q; Ramirez-Solano M; Milne GL; Sanchez S; Wang ZY; Bjorling DE; Miller NL; Matusik RJ
    Prostate; 2021 Sep; 81(13):944-955. PubMed ID: 34288015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis.
    Gacci M; Corona G; Sebastianelli A; Serni S; De Nunzio C; Maggi M; Vignozzi L; Novara G; McVary KT; Kaplan SA; Gravas S; Chapple C
    Eur Urol; 2016 Nov; 70(5):788-796. PubMed ID: 27451136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dansylation isotope labeling liquid chromatography mass spectrometry for parallel profiling of human urinary and fecal submetabolomes.
    Su X; Wang N; Chen D; Li Y; Lu Y; Huan T; Xu W; Li L; Li L
    Anal Chim Acta; 2016 Jan; 903():100-9. PubMed ID: 26709303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The diagnostic value of abdominal ultrasound, urine cytology and prostate-specific antigen testing in the lower urinary tract symptoms clinic.
    Patel NS; Blick C; Kumar PV; Malone PR
    Int J Clin Pract; 2009 Dec; 63(12):1734-8. PubMed ID: 19930334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of hexanic extract of Serenoa repens (Permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia.
    Latil A; Pétrissans MT; Rouquet J; Robert G; de la Taille A
    Prostate; 2015 Dec; 75(16):1857-67. PubMed ID: 26306400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial.
    Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal AC; Castro-Santamaria R; Freedland SJ
    Eur Urol; 2016 May; 69(5):885-91. PubMed ID: 26724841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
    Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S
    Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can We Rely Solely on the International Prostate Symptoms Score to Investigate Storage Symptoms in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement? Findings from a Cross-sectional Study.
    Pozzi E; Boeri L; Capogrosso P; Cazzaniga W; Candela L; Fallara G; Schifano N; Costa A; Cignoli D; Tutolo M; Matloob R; Abbate C; Montorsi F; Salonia A
    Eur Urol Focus; 2022 Mar; 8(2):555-562. PubMed ID: 33757736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invited commentary: Lower urinary tract symptoms and inflammation--weighing the evidence.
    Freedland SJ; Aronson WJ
    Am J Epidemiol; 2009 Jun; 169(11):1291-3; discussion 1294-5. PubMed ID: 19395692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary proteome and metabolome in dogs (Canis lupus familiaris): The effect of chronic kidney disease.
    Ferlizza E; Isani G; Dondi F; Andreani G; Vasylyeva K; Bellei E; Almeida AM; Matzapetakis M
    J Proteomics; 2020 Jun; 222():103795. PubMed ID: 32335294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary metabolomic profiling for noninvasive diagnosis of acute T cell-mediated rejection after kidney transplantation.
    Kim SY; Kim BK; Gwon MR; Seong SJ; Ohk B; Kang WY; Lee HW; Jung HY; Cho JH; Chung BH; Lee SH; Kim YH; Yoon YR; Kim CD; Cho S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1118-1119():157-163. PubMed ID: 31054449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting amine- and phenol-containing metabolites in urine by dansylation isotope labeling and liquid chromatography mass spectrometry for evaluation of bladder cancer biomarkers.
    Chen YT; Huang HC; Hsieh YJ; Fu SH; Li L; Chen CL; Chu LJ; Yu JS
    J Food Drug Anal; 2019 Apr; 27(2):460-474. PubMed ID: 30987717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population.
    Park JS; Koo KC; Kim HK; Chung BH; Lee KS
    Medicine (Baltimore); 2019 Oct; 98(42):e17635. PubMed ID: 31626149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
    Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute effects of moderate vs. vigorous endurance exercise on urinary metabolites in healthy, young, physically active men-A multi-platform metabolomics approach.
    Kistner S; Mack CI; Rist MJ; Krüger R; Egert B; Biniaminov N; Engelbert AK; Seifert S; Dörr C; Ferrario PG; Neumann R; Altmann S; Bub A
    Front Physiol; 2023; 14():1028643. PubMed ID: 36798943
    [No Abstract]   [Full Text] [Related]  

  • 38. Lower urinary tract symptoms are associated with low levels of serum serotonin, high levels of adiponectin and fasting glucose, and benign prostatic enlargement.
    Haghsheno MA; Mellström D; Peeker R; Hammarsten J; Lorentzon M; Sundh V; Karlsson M; Ohlsson C; Damber JE
    Scand J Urol; 2015 Apr; 49(2):155-61. PubMed ID: 25253423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score.
    Markin PA; Brito A; Moskaleva N; Lartsova EV; Shpot YV; Lerner YV; Mikhajlov VY; Potoldykova NV; Enikeev DV; La Frano MR; Appolonova SA
    Metabolomics; 2020 Jun; 16(7):74. PubMed ID: 32556743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics.
    Kumar BS; Chung BC; Kwon OS; Jung BH
    J Appl Toxicol; 2012 Jul; 32(7):505-20. PubMed ID: 22131085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.